{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:33Z","timestamp":1792181253310,"version":"4.4.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2024.105708","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:30:16Z","timestamp":1734481816000},"page":"105708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia, a decade after the discovery of MYD88L265P"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-4587","authenticated-orcid":false,"given":"Lianqun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.humpath.2024.105708_bib1","first-page":"32","article-title":"Incipient myelomatosis or \u201cessential\u201d hyperglobulinemia with fibrinogenopenia \u2013 a new syndrome?","volume":"117","author":"Waldenstr\u00f6m","year":"1944","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","article-title":"Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients","volume":"123","author":"Lin","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"8580","key":"10.1016\/j.humpath.2024.105708_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/1097-0142(195607\/08)9:4<792::AID-CNCR2820090429>3.0.CO;2-B","article-title":"Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases","volume":"9","author":"Hicks","year":"1956","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib7","first-page":"241","article-title":"The Lukes and Collins classification of non-Hodgkin's lymphomas. I. A histological reappraisal of 301 cases","volume":"90","author":"Alavaikko","year":"1982","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2024.105708_bib9","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.humpath.2024.105708_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humpath.2024.105708_bib11","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project","volume":"49","year":"1982","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.pap.0000184176.65919.17","article-title":"Lymphoplasmacytic lymphoma\/waldenstrom macroglobulinemia: an evolving concept","volume":"12","author":"Lin","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib14","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2024.105708_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105708_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2022.10.005","article-title":"Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms","volume":"130","author":"Qiu","year":"2022","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcp\/aqw072","article-title":"Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and May Harbor MYD88 L265P mutations","volume":"145","author":"King","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ajh.25600","article-title":"Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network","volume":"94","author":"Varettoni","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib20","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/10428194.2020.1719100","article-title":"A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia","volume":"61","author":"Castillo","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3","article-title":"Waldenstrom's macroglobulinemia: incidence patterns in the United States, 1988-1994","volume":"82","author":"Groves","year":"1998","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.humpath.2024.105708_bib22","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/cncr.26627","article-title":"Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study","volume":"118","author":"Wang","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdj111","article-title":"Characterization of familial Waldenstrom's macroglobulinemia","volume":"17","author":"Treon","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminhematol.2023.03.008","article-title":"The epidemiology of Waldenstr\u00f6m macroglobulinemia","volume":"60","author":"McMaster","year":"2023","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pathol.2019.09.009","article-title":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinaemia: clinicopathological features and differential diagnosis","volume":"52","author":"Wang","year":"2020","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/bjh.14492","article-title":"Investigation and management of IgM and Waldenstrom-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel","volume":"176","author":"D'Sa","year":"2017","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.1993.11.5.914","article-title":"Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia","volume":"11","author":"Gertz","year":"1993","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.01.010","article-title":"Autologous stem cell transplantation for patients with multiple myeloma with translocation (4;14): the MD Anderson cancer center experience","volume":"29","author":"Pasvolsky","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.humpath.2024.105708_bib29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"issue":"18","key":"10.1016\/j.humpath.2024.105708_bib30","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","article-title":"Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia","volume":"123","author":"Treon","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjh.13361","article-title":"MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity","volume":"169","author":"Schmidt","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr\u00f6m macroglobulinaemia treated with ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105708_bib33","series-title":"WHO classification of haematolymphoid tumours","first-page":"394","article-title":"Lymphoplasmacytic lymphoma","author":"Montes-Moreno","year":"2024"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2023.05.001","article-title":"Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: what we learned, and how it will impact scientific discovery and patient care","volume":"60","author":"Treon","year":"2023","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.1983.tb00664.x","article-title":"Bone marrow histology in Waldenstr\u00f6m's macroglobulinaemia. Clinical relevance of subtype recognition","volume":"31","author":"Bartl","year":"1983","journal-title":"Scand J Haematol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105708_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","article-title":"Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients","volume":"27","author":"Lin","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/9DBY-FBUG-Y10A-AAXT","article-title":"Lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia associated with Hodgkin disease. A report of two cases","volume":"116","author":"Rosales","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/R01VXG46MFCDVNHL","article-title":"Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Clinicopathologic features of 12 cases","volume":"120","author":"Lin","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"15","key":"10.1016\/j.humpath.2024.105708_bib40","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","article-title":"The cellular origin and malignant transformation of Waldenstr\u00f6m macroglobulinemia","volume":"125","author":"Paiva","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","article-title":"Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia","volume":"124","author":"Konoplev","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/leu.2013.124","article-title":"Multiparameter flow cytometry for the identification of the Waldenstr\u00f6m's clone in IgM-MGUS and Waldenstr\u00f6m's Macroglobulinemia: new criteria for differential diagnosis and risk stratification","volume":"28","author":"Paiva","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/sonc.2003.50074","article-title":"Immunophenotypic analysis of Waldenstrom's macroglobulinemia","volume":"30","author":"San Miguel","year":"2003","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41375-022-01762-3","article-title":"Diagnostics in Waldenstr\u00f6m's macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m's Macroglobulinemia","volume":"37","author":"Dogliotti","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.13996","article-title":"To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenstrom Macroglobulinaemia","volume":"176","author":"Gustine","year":"2017","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1016\/j.humpath.2024.105708_bib46","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"7332","key":"10.1016\/j.humpath.2024.105708_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.humpath.2024.105708_bib48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"7354","key":"10.1016\/j.humpath.2024.105708_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.humpath.2024.105708_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41408-020-00351-w","article-title":"Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features","volume":"10","author":"Shuai","year":"2020","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15049","article-title":"MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival","volume":"180","author":"Treon","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.humpath.2024.105708_bib53","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3324\/haematol.2019.227272","article-title":"MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications","volume":"104","author":"de Groen","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.hoc.2023.04.002","article-title":"Clinical implications of genomic profile in Waldenstr\u00f6m macroglobulinemia","volume":"37","author":"Moreno","year":"2023","journal-title":"Hematol Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.18502","article-title":"Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstrom macroglobulinaemia","volume":"200","author":"Moreno","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl4644","article-title":"Preneoplastic somatic mutations including MYD88(L265P) in lymphoplasmacytic lymphoma","volume":"8","author":"Rodriguez","year":"2022","journal-title":"Sci Adv"},{"issue":"8","key":"10.1016\/j.humpath.2024.105708_bib57","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050227","article-title":"Clonal architecture and evolutionary history of Waldenstr\u00f6m's macroglobulinemia at the single-cell level","volume":"16","author":"Garc\u00eda-Sanz","year":"2023","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib58","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1002\/hem3.27","article-title":"Single-cell analysis of MYD88(L265P) and MYD88(WT) Waldenstr\u00f6m macroglobulinemia patients","volume":"8","author":"Bagratuni","year":"2024","journal-title":"Hemasphere"},{"issue":"21","key":"10.1016\/j.humpath.2024.105708_bib59","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstr\u00f6m macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib60","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1158\/1078-0432.CCR-15-0646","article-title":"Genomic landscape of CXCR4 mutations in Waldenstrom macroglobulinemia","volume":"22","author":"Poulain","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","article-title":"CXCR4 in Waldenstr\u00f6m's Macroglobulinema: chances and challenges","volume":"35","author":"Kaiser","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjh.13897","article-title":"Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr\u00f6m macroglobulinaemia","volume":"172","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib63","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1200\/JCO.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00277-017-3207-3","article-title":"Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study","volume":"97","author":"Jimenez","year":"2018","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15560","article-title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr\u00f6m macroglobulinaemia","volume":"184","author":"Gustine","year":"2019","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.humpath.2024.105708_bib66","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-17-0007","article-title":"TP53 mutation and its prognostic significance in Waldenstrom's macroglobulinemia","volume":"23","author":"Poulain","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.17028","article-title":"6q deletion in Waldenstrom macroglobulinaemia negatively affects time to transformation and survival","volume":"192","author":"Garcia-Sanz","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","article-title":"Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course","volume":"116","author":"Mansoor","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2024.105708_bib69","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ajh.26339","article-title":"Cytogenetic and molecular abnormalities in Waldenstr\u00f6m's macroglobulinemia patients: correlations and prognostic impact","volume":"96","author":"Krzisch","year":"2021","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/507687","article-title":"Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families","volume":"79","author":"McMaster","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.humpath.2024.105708_bib71","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2008-06-162768","article-title":"Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia patients: a population-based study in Sweden","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib72","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1038\/s41467-018-06541-2","article-title":"Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia","volume":"9","author":"McMaster","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100013","article-title":"The landscape of rare genetic variants in familial Waldenstrom macroglobulinemia","volume":"1","author":"Pemov","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/jha2.573","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: a diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis","volume":"3","author":"Garc\u00eda-Abell\u00e1s","year":"2022","journal-title":"EJHaem"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib75","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/10428194.2021.2018584","article-title":"Discriminating between Waldenstr\u00f6m macroglobulinemia and marginal zone lymphoma using logistic LASSO regression","volume":"63","author":"Amaador","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.humpath.2024.105708_bib76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jclinpath-2019-206282","article-title":"Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinaemia and description of its mutational profiles by targeted NGS","volume":"73","author":"Garcia-Reyero","year":"2020","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105708_bib78","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/j.humpath.2024.105708_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416136","article-title":"LAIR1, an ITIM-containing receptor involved in immune disorders and in hematological neoplasms","volume":"23","author":"Van Laethem","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","article-title":"Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin","volume":"480","author":"Vela","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2024.105708_bib81","first-page":"1465","article-title":"Deletion 7q is associated with KLF2 and NOTCH2 mutations and is strongly correlated with splenic marginal zone lymphoma but also found in lymphoplasmacytic lymphoma and hairy cell leukemia variant","volume":"130","author":"H\u00f6llein","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"Watkins","year":"2010","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib83","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86 patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105708_bib128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ajcp\/aqad048","article-title":"The Histopathology of Cold Agglutinin Disease-Associated B-Cell Lymphoproliferative Disease","volume":"160","author":"Guenther","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.humpath.2024.105708_bib86","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2016.146126","article-title":"Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity","volume":"101","author":"Malecka","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib87","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3109\/10428194.2013.779689","article-title":"Clues to pathogenesis of Waldenstrom macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors","volume":"54","author":"Varettoni","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2024.105708_bib88","series-title":"WHO classification of haematolymphoid tumours","first-page":"599","article-title":"Cold agglutinin disease","author":"Naresh","year":"2014"},{"key":"10.1016\/j.humpath.2024.105708_bib89","unstructured":"Rajkumar SV; Fernandez De Larrea C KS, Landgren OC. Non-IgM monoclonal gammopathy of undetermined significance WHO Classification of Haematolymphoid Tumours, pp. 603-604."},{"key":"10.1016\/j.humpath.2024.105708_bib90","series-title":"WHO classification of haematolymphoid tumours","first-page":"602","article-title":"IgM monoclonal gammopathy of undetermined significance","author":"Rajkumar","year":"2024"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2023.03.009","article-title":"Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria","volume":"60","author":"Treon","year":"2023","journal-title":"Semin Hematol"},{"key":"10.1016\/j.humpath.2024.105708_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.humpath.2018.09.008","article-title":"IgM plasma cell myeloma in the era of novel therapy: a clinicopathological study of 17 cases","volume":"84","author":"Angelova","year":"2019","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105708_bib93","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2014.108688","article-title":"Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma","volume":"99","author":"Hamadeh","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13000-022-01244-1","article-title":"Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma","volume":"17","author":"Baloda","year":"2022","journal-title":"Diagn Pathol"},{"issue":"26","key":"10.1016\/j.humpath.2024.105708_bib95","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2024.105708_bib96","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.13041117","article-title":"Kidney involvement of patients with Waldenstrom macroglobulinemia and other IgM-producing B cell lymphoproliferative disorders","volume":"13","author":"Higgins","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib97","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.14279","article-title":"Renal disease related to Waldenstrom macroglobulinaemia: incidence, pathology and clinical outcomes","volume":"175","author":"Vos","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib98","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pathol.2018.10.022","article-title":"Biclonal presentation of lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinaemia","volume":"51","author":"Wang","year":"2019","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/ol.2023.13683","article-title":"Biclonal lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia associated with POEMS syndrome: a case report and literature review","volume":"25","author":"Wang","year":"2023","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib100","first-page":"10","article-title":"Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge","volume":"7","author":"Mansour","year":"2017","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.humpath.2024.105708_bib101","first-page":"275","article-title":"Multiple myeloma includes phenotypically defined subsets of clonotypic CD20+ B cells that persist during treatment with rituximab","volume":"2","author":"Pilarski","year":"2008","journal-title":"Clin Med Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib102","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminhematol.2023.03.007","article-title":"Report of consensus panel 3 from the 11th international workshop on Waldenstr\u00f6m\u2019s macroglobulinemia: recommendations for molecular diagnosis in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"60","author":"Garcia-Sanz","year":"2023","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105708_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26184","article-title":"Cell-free DNA analysis for detection of MYD88(L265P) and CXCR4(S338X) mutations in Waldenstr\u00f6m macroglobulinemia","volume":"96","author":"Demos","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib104","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1002\/ajh.25802","article-title":"Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations","volume":"95","author":"Ntanasis-Stathopoulos","year":"2020","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105708_bib105","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000624","article-title":"Diagnostic next-generation sequencing frequently fails to detect MYD88(L265P) in Waldenstr\u00f6m macroglobulinemia","volume":"5","author":"Kofides","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.humpath.2024.105708_bib106","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.17385","article-title":"Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenstrom macroglobulinaemia","volume":"194","author":"Gustine","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105708_bib107","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.2017.186528","article-title":"Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenstrom macroglobulinemia","volume":"103","author":"Drandi","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib108","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/bloodadvances.2021005354","article-title":"Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies","volume":"6","author":"Bagratuni","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105708_bib109","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/blood.2022017235","article-title":"How we use genomics and BTK-inhibitors in the treatment of Waldenstrom macroglobulinemia","volume":"143","author":"Treon","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/17474086.2023.2270779","article-title":"New developments in the diagnosis and characterization of Waldenstr\u00f6m's macroglobulinemia","volume":"16","author":"Garc\u00eda-Sanz","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.humpath.2024.105708_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2024.01.012","article-title":"Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: two cases of leukemic non-nodal mantle cell lymphoma","volume":"144","author":"Quesada","year":"2024","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib112","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstrom macroglobulinaemia treated with ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib113","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1309\/AJCP15YFULCZHZVH","article-title":"Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy","volume":"135","author":"Barakat","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2023.03.005","article-title":"Report of consensus panel 1 from the 11(th) International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-na\u00efve patients","volume":"60","author":"Buske","year":"2023","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2023.03.003","article-title":"Report of consensus panel 2 from the 11th international workshop on Waldenstr\u00f6m's macroglobulinemia on the management of relapsed or refractory WM patients","volume":"60","author":"D'Sa","year":"2023","journal-title":"Semin Hematol"},{"key":"10.1016\/j.humpath.2024.105708_bib116","unstructured":"https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/waldenstroms.pdf."},{"key":"10.1016\/j.humpath.2024.105708_bib117","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221093962","article-title":"Treatment paradigm in Waldenstrom macroglobulinemia: frontline therapy and beyond","volume":"13","author":"Zanwar","year":"2022","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib118","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/bloodadvances.2021006106","article-title":"Response and survival predictors in a cohort of 319 patients with Waldenstrom macroglobulinemia treated with ibrutinib monotherapy","volume":"6","author":"Castillo","year":"2022","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.humpath.2024.105708_bib119","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood-2014-05-574871","article-title":"Survival trends in Waldenstrom macroglobulinemia: an analysis of the surveillance, epidemiology and end results database","volume":"123","author":"Castillo","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105708_bib120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/bjh.13264","article-title":"Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database","volume":"169","author":"Castillo","year":"2015","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105708_bib121","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/s41375-019-0431-y","article-title":"A revised international prognostic score system for Waldenstrom's macroglobulinemia","volume":"33","author":"Kastritis","year":"2019","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.humpath.2024.105708_bib122","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"issue":"1d","key":"10.1016\/j.humpath.2024.105708_bib123","article-title":"Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Kumar","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2024.105708_bib124","unstructured":"https:\/\/www.awmrisk.com\/. (Accessed October 6th 2024)."},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajh.24955","article-title":"MYD88 mutation status does not impact overall survival in Waldenstr\u00f6m macroglobulinemia","volume":"93","author":"Abeykoon","year":"2018","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105708_bib126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ajh.25697","article-title":"Impact of MYD88(L265P) mutation status on histological transformation of Waldenstr\u00f6m Macroglobulinemia","volume":"95","author":"Zanwar","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105708_bib127","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/10428194.2014.924123","article-title":"MYD88 mutant lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart","volume":"56","author":"Patkar","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772400217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772400217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:42:05Z","timestamp":1741297325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772400217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":128,"alternative-id":["S004681772400217X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105708","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia, a decade after the discovery of MYD88L265P","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105708"}}